摘要
化疗是目前晚期胰腺癌内科治疗的重要手段，吉西他滨为标准用药，以其为基础的综合治疗方案在不断探索中，并取得一定进展。放疗同期化疗的应用存在一定争议，尚待进一步的研究证实。新辅助治疗的出现，使部分进展期胰腺癌患者获得了肿瘤切除的可能，对延长生存期意义重大。靶向治疗的出现为转移性胰腺癌患者带来了希望，提高了生存获益。
Chemotherapy is an important means for advanced pancreatic cancer currently. Gemcitabine is the standard therapy, comprehensive treatment regimens are in continuous exploration, and have made some progress. There are some disputes in the application of chemoradiotherapy, the effect needs further study to confirm. Neoadjuvant therapy,making some advanced pancreatic tumors possible to be resected, has great significance in prolonging the survival time. Targeted therapy brings hope for metastatic pancreatic cancer, which improves the survival benefit.
出处
《国际肿瘤学杂志》
CAS
2009年第8期625-628,共4页
Journal of International Oncology
基金
基金项目：吴阶平医学基金会资助项目（KT07-25）
关键词
胰腺肿瘤
药物疗法
放射疗法
靶向治疗
Pancreatic neoplasms
Drug therapy
Radiotherapy
Targeted therapy
